BIA
ACAD icon

Bell Investment Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bell Investment Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-91
Closed -$1.51K – 1880
2025
Q1 		$1.51K Buy
91
+28
+44% +$509 ﹤0.01% 1409
2024
Q4 		$1.16K Hold
63
– – ﹤0.01% 1540
2024
Q3 		$969 Buy
+63
New +$1.05K ﹤0.01% 1600
2024
Q1 		– Sell
-30
Closed -$940 – 1910
2023
Q4 		$940 Buy
+30
New +$716 ﹤0.01% 1614
2023
Q3 		– Sell
-19
Closed -$456 – 1924
2023
Q2 		$456 Buy
+19
New +$422 ﹤0.01% 1876
2022
Q3 		– Sell
-29
Closed – – 1699
2022
Q2 		$0 Buy
+29
New +$541 ﹤0.01% 1713
2021
Q4 		$4K Buy
163
+134
+462% +$2.69K ﹤0.01% 823
2021
Q3 		$0 Buy
+29
New +$559 ﹤0.01% 1706

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return